Search For "antibody cocktail"
Rapid rise in COVID-19 cases in Kerala could be due to Omicron, says Keral
Updated : 4 years, 4 months ago IST
Thiruvananthapuram (Kerala) [India], January 19 (ANI): The rising cases of COVID-19 in Kerala could be due to the presence of the Omicron variant of the virus, said Dr GS Vijayakrishnan, the President of Kerala Government Medical Officers Association on Tuesday.
Read More
COVID treatment guidelines don't include Molnupiravir, Monoclonal antibody
Updated : 4 years, 4 months ago IST
New Delhi [India], January 18 (ANI): According to the revised guidelines issued by AIIMS, ICMR - COVID 19 National Task Force and Joint Monitoring Group (DGHS) under Union Health Ministry for management of adult COVID-19 patients, there is no evidence of injectable steroids in those who does
Read More
Antibody cocktail not useful for most patients with Omicron: Experts
Updated : 4 years, 4 months ago IST
Kolkata (West Bengal) [India], January 5 (ANI): Amid the surge in COVID cases and concerns over the Omicron variant of coronavirus, doctors in Kolkata believe that there is no requirement for antibody cocktail for most of the patients as the formula is not useful for the Omicron variant of c
Read More
AstraZeneca's antibody treatment fails to protect against COVID-19
Updated : 4 years, 11 months ago IST
Moscow [Russia], June 15 (ANI/Sputnik): AstraZeneca announced on Tuesday that the clinical trial of its long-acting antibody cocktail has not provided evidence of effectiveness in protecting people exposed to the coronavirus.
Read More
Apollo Hospitals MD says antibody cocktail therapy made dramatic differenc
Updated : 4 years, 11 months ago IST
New Delhi [India], June 14 (ANI): Apollo Hospitals Managing Director Dr Sangeeta Reddy on Monday said that the antibody cocktail Regeneron treatment she took after contracting Covid-19 made a dramatic difference in her recovery from the infection.
Read More
Monoclonal Antibody treatment begins at Delhi's LNJP hospital
Updated : 4 years, 11 months ago IST
New Delhi [India], June 6 (ANI): The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" patients who are Covid positive is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) free of cost.
Read More
Two high risk COVID-19 patients pulled out of danger using antibody cockta
Updated : 4 years, 11 months ago IST
New Delhi [India], June 3 (ANI): A Delhi Hospital on Tuesday pulled two high-risk senior citizen COVID-19 patients out of danger by administering Monoclonal Antibody Cocktail (MAC) therapy.
Read More
COVID-19: Delhi's Sir Gangaram Hospital begins monoclonal antibody cocktai
Updated : 4 years, 11 months ago IST
New Delhi [India], June 1 (ANI): Delhi's Sir Gangaram Hospital on Tuesday commenced administration of Monoclonal Antibody Cocktail (MAC) to coronavirus patients, the medical facility said in a statement.
Read More
Eli Lilly's antibody cocktail drug gets emergency use nod in India
Updated : 4 years, 11 months ago IST
New Delhi [India], June 1 (ANI): Eli Lilly and Company India on Tuesday announced that it has received emergency use approval in the country for its monoclonal antibody drug combination used for treating Covid-19 patients with mild to moderate symptoms.
Read More
Monoclonal antibody cocktail unlikely to cause further mutations of COVID-
Updated : 4 years, 12 months ago IST
New Delhi [India], May 30 (ANI): Monoclonal antibody cocktail, used for the treatment of COVID-19, is unlikely to lead to further mutation of the virus, said Dr Raman R Gangakhedkar, former Head Scientist of Epidemiology and Communicable Diseases at the Indian Council of Medical Research (IC
Read More
Tamil Nadu's first SARS-CoV-2 antibody cocktail treatment for COVID-19 beg
Updated : 4 years, 12 months ago IST
Chennai (Tamil Nadu) [India], May 28 (ANI/NewsVoir): A new entrant into the treatment portfolio of COVID-19 in India is the cocktail formulation of Mono Clonal Antibodies (MCAb).
Read More
COVID antibody cocktail now offered to patients at Indraprastha Apollo Hos
Updated : 4 years, 12 months ago IST
New Delhi [India], May 28 (ANI): Roche India's Antibody Cocktail (Casirivimab and Imdevimab) is now available as a therapy to treat patients with mild and moderate COVID-19 infection at the Indraprastha Apollo Hospitals in Delhi, the hospital said in a statement on Friday.
Read More